Episode 125| Inside Tech Transfer At UCLA From Patents To Patients

A single university discovery can turn into a life-changing therapy, but only if someone can translate the science into a product, a company, and a development plan investors will actually fund. That is why we sat down with Mark from UCLA’s technology transfer and licensing team to demystify what happens after the lab result and before the biotech headline. We talk plainly about what a tech transfer office does, what it can license, and why “intellectual property” now stretches beyond patents into data, materials, and even carefully governed patient datasets. We also zoom out to the policy foundation that made modern university commercialization possible: the Bayh-Dole Act. Mark explains how shifting IP ownership from the federal government to universities changed licensing outcomes and helped build the innovation ecosystem we now associate with US leadership in therapeutics. Along the way, we connect the dots to real UCLA impact, including major prostate cancer drugs and a licensed cure for ADA-SCID, and we unpack the tension founders often feel when a faculty inventor becomes a startup founder negotiating with their own campus. Then we get tactical. We break down why big pharma often waits until risk is reduced, why faculty-led startups become the bridge, and how license strategy changes depending on whether you are building a therapeutic that needs exclusivity or a platform that benefits from nonexclusive access. Mark walks through diligence milestones, annual progress reporting, and the practical reality that most “shelving” is not malicious, it is a startup fighting for survival. If you care about biotech startups, university patents, and the future of the Los Angeles bioscience ecosystem, this conversation is a roadmap. If this helped you see tech transfer differently, subscribe, share the episode with a founder or researcher, and leave a review telling us what part of the university-to-startup journey you want us to unpack next. Show notes: coming soon YouTube: coming soon Send us Fan Mail Support the show Subscribe to our premium version and support the show. Follow us: Twitter Instagram Linkedin 3DHEALS Website Facebook Facebook Group Youtube channel About Pitch3D